Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurocysticercosis.

Christopher M DeGiorgio1, Marco T Medina, Reyna Durón

  • 1cmd@mednet.ucla.edu

Epilepsy Currents
|August 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charlotte Dravet: Life and contributions to epileptology.

Epilepsia·2026
Same author

Is Cardiovascular Mortality Among People with Epilepsy increasing? A retrospective US population study.

BMJ open·2025
Same author

Oxygen-15 Labeled Water Positron Emission Tomography During External Trigeminal Nerve Stimulation.

Neuromodulation : journal of the International Neuromodulation Society·2025
Same author

Population genetic data for 23 STR loci (PowerPlex Fusion 6C™ kit) genetic markers in the Lenca ethnic group in Honduras.

Legal medicine (Tokyo, Japan)·2024
Same author

Should neurologists initiate treatment for hypertension and hyperlipidemia to reduce cardiovascular risk in epilepsy?

Frontiers in neurology·2024
Same author

Increased cardiovascular risk in epilepsy.

Frontiers in neurology·2024

Neurocysticercosis, a common cause of seizures, may be treated with antiparasitic drugs. New evidence suggests these medications are effective for select patients experiencing active cysts and seizures.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Parasitology

Background:

  • Neurocysticercosis is a significant cause of epilepsy globally, particularly in developing nations.
  • It is also an emerging health concern in the United States.
  • Taenia solium infection leads to neurocysticercosis, impacting the central nervous system.

Purpose of the Study:

  • To evaluate the efficacy of antiparasitic agents in treating neurocysticercosis.
  • To provide evidence for the management of active cysts and associated seizures.

Main Methods:

  • Analysis of recent findings from the Cysticercosis Working Group in Peru.
  • Focus on highly selected patient cohorts with active neurocysticercosis cysts and seizures.

Main Results:

Related Experiment Videos

  • New evidence supports the use of antiparasitic agents.
  • Treatment appears beneficial in specific patient groups with active disease.

Conclusions:

  • Antiparasitic therapy is a viable option for select neurocysticercosis patients.
  • Further research may refine treatment protocols for this condition.